Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this trial is that the therapeutic activity and safety of oral miltefosine
in Brazilian patients with cutaneous leishmaniasis is similar or superior to the intravenous
standard treatment (meglumine antimoniate - Glucantime®).
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Universitário Professor Edgard Santos
Collaborators:
AEterna Zentaris Conselho Nacional de Desenvolvimento Científico e Tecnológico Ministério da Saúde Ministerio de Ciencia e Innovación, Spain